Erythema multiforme major

From WikiMD's Medical Encyclopedia

Revision as of 00:52, 20 February 2025 by Prab (talk | contribs) (CSV import)

Erythema multiforme major is a form of skin disease that is characterized by the sudden onset of red, target-like spots or patches on the skin. It is a severe and potentially life-threatening condition that requires immediate medical attention.

Causes

The exact cause of erythema multiforme major is unknown, but it is often associated with infections, particularly herpes simplex virus and Mycoplasma pneumoniae. It can also be triggered by certain medications, including sulfa drugs, penicillins, barbiturates, and phenytoin.

Symptoms

The primary symptom of erythema multiforme major is the sudden onset of red, target-like spots or patches on the skin. These spots often start on the extremities and spread towards the center of the body. Other symptoms may include fever, general ill feeling, itching of the skin, joint aches, and abnormal leukocyte count.

Diagnosis

Diagnosis of erythema multiforme major is typically based on the characteristic appearance of the skin lesions. Additional tests may be performed to rule out other conditions and to identify any underlying causes. These tests may include a skin biopsy, blood tests, and tests for specific infections.

Treatment

Treatment for erythema multiforme major is primarily supportive and aimed at relieving symptoms. This may include the use of corticosteroids to reduce inflammation, antihistamines to relieve itching, and pain medications to manage discomfort. If an underlying infection is identified, appropriate antibiotics or antiviral medications may be prescribed.

Prognosis

The prognosis for erythema multiforme major varies depending on the severity of the condition and the individual's overall health. With appropriate treatment, most people recover within 2 to 6 weeks. However, the condition can recur, particularly in individuals with herpes simplex virus.

See also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99

W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss

Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots

Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:

✔ Most insurances accepted for visits ✔ Prior authorization support when eligible

Start your physician weight loss NYC journey today:

📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center

📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)

Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss


Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.